IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

5/13/25 2:30:00 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Get the next $IDXX alert in real time by email

IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financial Officer, and Tina Hunt, Executive Vice President, Global Strategy and Commercial, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 28, 2025 from 10:55 am – 11:25 am (EDT).

A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will be available via the same link.

2025 Investor Day

IDEXX Laboratories, Inc. also announced today that it will host its 2025 Investor Day on Thursday, August 14, 2025 at its corporate headquarters in Westbrook, Maine from approximately 8:00 am to 12:00 pm (EDT). A live webcast of the presentations will be available on www.idexx.com/investors. Advance registration for the in-person event is required; institutional investors and analysts interested in attending should contact [email protected]. Additional information on IDEXX's Investor Day will be provided closer to the date of the event.

About IDEXX Laboratories, Inc.

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500^® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries. For more information about IDEXX, visit www.idexx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250513514945/en/

Investor Relations

[email protected]

Get the next $IDXX alert in real time by email

Recent Analyst Ratings for

$IDXX

Date	Price Target	Rating	Analyst
12/2/2024	$500.00	Outperform	Leerink Partners
7/25/2024	$580.00	Buy	BTIG Research
1/30/2024	$525.00	Overweight → Neutral	Piper Sandler
12/7/2023	$602.00	Outperform	Exane BNP Paribas
12/4/2023		Neutral → Buy	Cleveland Research
8/2/2023	$610.00	Overweight → Neutral	Atlantic Equities
7/25/2022	$415.00	Buy → Hold	Stifel
7/21/2022	$530.00 → $435.00	Neutral → Buy	Goldman

More analyst ratings

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

Chat with this insight

Recent Analyst Ratings for
$IDXX

$IDXX
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Executive Vice President Johnson Michael Perkins covered exercise/tax liability with 1,499 shares and converted options into 3,382 shares, increasing direct ownership by 390% to 2,365 units (SEC Form 4)

Director Szostak M Anne exercised 1,046 shares at a strike of $160.28 and sold $1,182,917 worth of shares (2,306 units at $512.97) (SEC Form 4)

Director Junius Daniel M exercised 2,683 shares at a strike of $263.81 and sold $1,358,697 worth of shares (2,683 units at $506.41) (SEC Form 4)

$IDXX
SEC Filings

SEC Form SD filed by IDEXX Laboratories Inc.

IDEXX Laboratories Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form 10-Q filed by IDEXX Laboratories Inc.

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

Chat with this insight

Recent Analyst Ratings for $IDXX

$IDXX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Executive Vice President Johnson Michael Perkins covered exercise/tax liability with 1,499 shares and converted options into 3,382 shares, increasing direct ownership by 390% to 2,365 units (SEC Form 4)

Director Szostak M Anne exercised 1,046 shares at a strike of $160.28 and sold $1,182,917 worth of shares (2,306 units at $512.97) (SEC Form 4)

Director Junius Daniel M exercised 2,683 shares at a strike of $263.81 and sold $1,358,697 worth of shares (2,683 units at $506.41) (SEC Form 4)

$IDXX SEC Filings

SEC Form SD filed by IDEXX Laboratories Inc.

IDEXX Laboratories Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form 10-Q filed by IDEXX Laboratories Inc.

Recent Analyst Ratings for
$IDXX

$IDXX
Insider Trading

$IDXX
SEC Filings